share_log

3 No-Brainer Stocks to Buy With $300 Right Now

3 No-Brainer Stocks to Buy With $300 Right Now

用300美元现在买入的3只不用动脑子的股票
The Motley Fool ·  07/24 16:00
big

Investing in shares can help you build wealth in the long term, although it comes with inherent risks. Nonetheless, some stocks are considered âno-brainersâ due to their fundamentally strong business models, solid financials, and potential for long-term growth. These companies have demonstrated resilience and adaptability in all market conditions, making them ideal choices for long-term investors.

投资股票可以帮助你长期稳健地积累财富,尽管这种投资方式存在固有风险。然而,一些股票由于其基本健康的商业模式、坚实的财务基础以及长期增长的潜力被认为是“毫无脑子”的选择。这些公司在所有市场环境下均表现出抗压性和适应性,是长期投资者的理想选择。

So, if you plan to invest in stocks with $300, here are three no-brainer Canadian stocks to consider.

所以,如果你打算以300美元的价格投资股票,这里有三个毫无脑子的加拿大股票可供选择。

No-brainer stock #1

毫无疑问的股票#1

Speaking of no-brainer stocks, investors could consider investing in goeasy (TSX:GSY) for its solid financials and long-term growth potential. This financial services company is an industry leader in Canadaâs non-prime lending sector. What stands out is that goeasy has consistently grown its revenue and earnings per share (EPS) at a solid double-digit rate, which has driven its share price and dividend distributions.

说到“毫无脑子”的股票,投资者可以考虑在goeasy(tsx:gsy)投资,因为它具有坚实的财务基础和长期增长的潜力。这家金融服务公司是加拿大次级贷款行业的领导者。它的优秀之处在于,goeasy已经以稳定的两位数速度增长收入和每股收益,推动了其股价和分红派息。

goeasyâs top line sports a compound annual growth rate (CAGR) of 20% in the last five years. At the same time, its EPS increased at a CAGR of 32.2%. Thanks to its stellar financials, goeasy stock has grown at a CAGR of nearly 34% in the last five years, delivering capital gains of about 332%. Moreover, it enhanced its shareholdersâ returns via higher dividend payments during the same time.

在过去五年中,goeasy的销售额复合年增长率(CAGR)为20%。同时,其每股收益以32.2%的CAGR增长。由于其杰出的财务状况,goeasy股票在过去五年中以近34%的CAGR增长,实现了约332%的资本增值。此外,它通过更高的股息支付提高了股东回报。

The momentum in goeasyâs business is likely to sustain in the coming years, driven by a large addressable market, omnichannel offerings, geographical expansion, and wide product range. These factors will drive goeasyâs loans and overall revenues. Further, the companyâs solid credit underwriting capabilities and focus on operating efficiency will likely cushion its earnings and dividend payments.

goeasy业务的势头有望在未来几年持续,受到大量可寻址市场、全渠道产品、地理扩张和宽广产品范围的推动。这些因素将推动goeasy的贷款和整体收入增长。此外,该公司坚实的信贷承销能力和专注于运营效率将缓冲其收益和分红派息。

Despite the uptrend in goeasy stock, it is still trading at the next 12-month (NTM) price-to-earnings multiple of 11.2, which is attractive given its higher EPS growth and a decent yield of 2.3%.

尽管goeasy股票处于上涨趋势,但它仍然以未来12个月(NTM)市盈率11.2的水平交易,这是有吸引力的,因为它具有更高的每股收益增长和2.3%的可观收益率。

No-brainer stock #2

毫无疑问的股票#2

WELL Health (TSX:WELL) is a leading digital healthcare company and the largest owner-operator of outpatient medical clinics in Canada. The company is growing rapidly and delivering solid financials. Moreover, WELL stock is trading cheap on the valuation front, providing an excellent opportunity for investing.

WELL Health(tsx:WELL)是一家领先的数字医疗保健公司,也是加拿大最大的门诊医疗诊所的所有者和运营商。该公司正在快速增长并提供坚实的财务基础。此外,WELL股票在估值方面交易廉价,为投资提供了绝佳机会。

The momentum in WELL Healthâs business will likely continue in 2024 and beyond, driven by higher omnichannel patient visits. Moreover, its focus on accretive acquisitions will likely accelerate its growth. Additionally, WELL Health is optimizing operations to enhance organic growth and profitability. By prioritizing capital-efficient growth opportunities, the company aims to leverage its cash flows to reduce debt and limit share issuance.

WELL Health业务的势头将在2024年及以后可能会继续推动,受益于更多的全渠道病人就诊。此外,其专注于增长的资产收购将加速其增长。此外,WELL Health正在进行运营优化,以提高有机增长和盈利能力。通过优先考虑资本效率的增长机会,该公司旨在利用其现金流降低债务并限制股份发行。

In Canada, WELL Health is set to strengthen its market leadership as the nationâs first pan-Canadian clinical network. Further, it has implemented a cost optimization program to enhance operational efficiency and profitability. Furthermore, WELL Health is investing in artificial intelligence (AI) technologies to develop new products that will support its growth.

在加拿大,WELL Health已成为全国首个泛加拿大临床网络的领导者。此外,它实施了成本优化计划,以提高运营效率和盈利能力。此外,WELL Health正在投资人工智能(AI)技术,开发将支持其增长的新产品。

No-brainer stock #3

毫无疑问的股票#3

Alimentation Couche-Tard (TSX:ATD) stock could be a solid addition to your portfolio. This company operates convenience stores, a defensive business known for its resilience and stability. The firm also engages in fuel retailing and provides electric vehicle (EV) charging.

Alimentation Couche-Tard(tsx:ATD)股票可能是你的投资组合的不错选择。该公司经营便利店业务,这是一个以其弹性和稳定性著称的防御性企业。该公司还从事燃油零售并提供电动汽车(EV)充电。

Couche-Tard has a proven track record of delivering robust earnings and consistently outperforming the broader market. Over the past decade, the companyâs adjusted EPS has grown at an impressive CAGR of 15.2%. This strong earnings growth has enabled the company to increase its dividends at a CAGR of 25.6% during the same period. Couche-Tard stock has grown at a CAGR of 16.6% over the last five years, translating into an overall capital gain of more than 115%.

Couche-Tard拥有提供强劲盈利和持续优于整个市场的记录。在过去的十年中,该公司调整后每股收益以15.2%的CAGR增长。这种强劲的盈利增长使该公司能够在同期内将其股息以25.6%的CAGR增长率提高。Couche-Tard股票在过去五年中以16.6%的CAGR增长,转化为总资本收益超过115%。

Couche-Tardâs extensive network of stores, the expansion of its private label products, and operating leverage will likely drive its financials. Furthermore, the companyâs solid balance sheet and ability to acquire and integrate companies will accelerate its growth rate and drive its share price and dividends.

Couche-Tard广泛的商店网络、私人标签产品的扩展以及运营杠杆将推动其财务状况。此外,该公司坚实的资产负债表以及收购和整合公司的能力将加速其增长率,并推动其股价和股息。

The post 3 No-Brainer Stocks to Buy With $300 Right Now appeared first on The Motley Fool Canada.

《财经邮报》加拿大版:300美元在眼前!这三只毫无脑子的股票必须买!

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发